Inotek Pharma (ITEK) Posts Narrwer-than-Expected Q1 Loss of 21c/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Inotek Pharma (ITEK) Posts Narrwer-than-Expected Q1 Loss of 21c/Share

Inotek Pharmaceuticals Corporation Reports First Quarter 2015 Operational and Financial Results

May 15, 2015 7:00 AM EDT

LEXINGTON, Mass.--(BUSINESS WIRE)-- Inotek Pharmaceuticals Corporation (NASDAQ: ITEK), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapies for glaucoma, today reported financial results and operational highlights for the quarter ended March 31, 2015.

During the first quarter of 2015, Inotek successfully completed its IPO raising gross proceeds of approximately $63 million in the initial public offering combined with a concurrent offering of convertible notes, commented David P. Southwell, President and Chief Executive Officer of Inotek. We are on schedule to initiate our first pivotal Phase 3 trial in the third quarter of 2015,... More